APA (7th ed.) Citation

Zhou, L., Yang, T., Zhang, S., Liu, D., Feng, C., Ni, J., . . . Ma, A. (2025). Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways. Journal of Molecular Medicine, 1-16. https://doi.org/10.1007/s00109-025-02555-8

Chicago Style (17th ed.) Citation

Zhou, Lirun, et al. "Targeting Myeloid Differentiation Protein 2 Ameliorates Rheumatoid Arthritis by Inhibiting Inflammation and Ferroptosis via MAPK and NF-κB Signaling Pathways." Journal of Molecular Medicine 2025: 1-16. https://doi.org/10.1007/s00109-025-02555-8.

MLA (9th ed.) Citation

Zhou, Lirun, et al. "Targeting Myeloid Differentiation Protein 2 Ameliorates Rheumatoid Arthritis by Inhibiting Inflammation and Ferroptosis via MAPK and NF-κB Signaling Pathways." Journal of Molecular Medicine, 2025, pp. 1-16, https://doi.org/10.1007/s00109-025-02555-8.